ADVERSE EVENTS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGIFN-ALFA AND RIBAVIRIN IN REAL-WORLD SETTING

被引：0
|
作者：
Shen, Sophie W. [1 ]
Dimitrova, Dessislava [1 ]
Hines, Patricia [2 ]
Gomez-Caminero, Andres [1 ]
机构：
[1] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA
[2] Bristol Myers Squibb, Ctr Observat Res & Data Sci, Hopewell, NJ USA
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：855A / 856A
页数：2
相关论文
共 50 条
  • [31] Prognostic factors of chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan
    Chang, C-K
    Tseng, K-C
    Lai, N-S
    Chou, A-L
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S73 - S73
  • [32] Ribavirin and interferon alfa therapy in patients with chronic hepatitis C - Preliminary observation
    Warunek, W
    Zejc-Bajsarowicz, M
    Zyrkowska-Bieda, T
    Librant-Suska, M
    Janas-Skulina, U
    Mach, T
    JOURNAL OF HEPATOLOGY, 2000, 32 : 204 - 204
  • [33] A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
    Swain, Mark G.
    Lai, Ming-Yang
    Shiffman, Mitchell L.
    Cooksley, W. Graham E.
    Zeuzem, Stefan
    Dieterich, Douglas T.
    Abergel, Armand
    Pessoa, Mario G.
    Lin, Amy
    Tietz, Andreas
    Connell, Edward V.
    Diago, Moises
    GASTROENTEROLOGY, 2010, 139 (05) : 1593 - 1601
  • [34] Early Gene Expression Profiles of Patients with Chronic Hepatitis C Treated with Pegylated Interferon-Alfa and Ribavirin
    Younossi, Zobair M.
    Baranova, Ancha
    Afendy, Arian
    Collantes, Rochelle
    Stepanova, Maria
    Manyam, Ganiraju
    Bakshi, Anita
    Sigua, Christopher L.
    Chan, Joanne P.
    Iverson, Ayuko A.
    Santini, Christopher D.
    Chang, Sheng-Yung P.
    HEPATOLOGY, 2009, 49 (03) : 763 - 774
  • [35] Adverse events associated with apremilast use and withdrawal for psoriasis in a real-world setting
    Lee, E. B.
    Amin, M.
    Egeberg, A.
    Wu, J. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (10) : E393 - E394
  • [36] Real-world management of immune-related adverse events in the community setting
    Johnson, D. B.
    Bruno, D.
    Rioth, M.
    Zhang, C.
    Palaia, J.
    Pisupati, R.
    Bond, C.
    Rosenblatt, L. C.
    Broome, R. G.
    Teka, M.
    Kluger, H.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1268 - S1269
  • [37] METABOLIC COMORBIDITIES IN A LARGE FRENCH REAL-LIFE COHORT OF PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN
    Ratziu, V.
    Ouzan, D.
    Tran, A.
    Denis, J.
    Mathurin, P.
    Poizot-Martin, I.
    Perlemutter, G.
    Pinta, A.
    Rouannet, S.
    Roudot-Thoraval, F.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S518 - S519
  • [38] Predicitive Factors for Nonresponse in Genotype 2/3 Infected Chronic Hepatitis C (CHC) Patients Treated With Peginterferon Alfa-2A (PEG) and Ribavirin (RBV) in Real Life Setting
    Petersen, Joerg
    Lutz, Thomas
    Link, Ralph
    Moog, Gero
    Baumgarten, Axel
    Schott, Eckart
    Schmidt, Wolfgang
    Witthoeft, Thomas
    Schnaitmann, Eiko
    Seidel, Matthias
    Rieke, Ansgar P.
    Simon, Karl Georg
    Herrmann, Andreas
    Herold, Christoph
    Klass, Dietmar M.
    Alshuth, Ulrich
    Buggisch, Peter
    Mauss, Stefan
    Hueppe, Dietrich
    GASTROENTEROLOGY, 2012, 142 (05) : S938 - S938
  • [39] PREDICTIVE FACTORS FOR NONRESPONSE IN GENOTYPE 2/3 INFECTED CHRONIC HEPATITIS C (CHC) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A (PEG) AND RIBAVIRIN (RBV) IN REAL LIFE SETTING
    Petersen, J.
    Lutz, T.
    Link, R.
    Moog, G.
    Baumgarten, A.
    Schott, E.
    Schmidt, W.
    Witthoeft, T.
    Schnaitmann, E.
    Seidel, M.
    Rieke, A.
    Simon, K. G.
    Herrmann, A.
    Herold, C.
    Klass, D.
    Alshuth, U.
    Buggisch, P.
    Mauss, S.
    Hueppe, D.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S454 - S454
  • [40] Effectiveness and security of chronic hepatitis C treatment in coinfected patients in real-world
    Uriarte-Pinto, Moises
    Navarro-Aznarez, Herminia
    De La Llama-Celis, Natalia
    Arazo-Garces, Piedad
    Maria Martinez-Sapina, Ana
    Reyes Abad-Sazatornil, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (03) : 608 - 616
12345